JIM CRAMERUsing Technical Analysis: Cramer's 'Mad Money' Recap (Friday 1/17/20)By Scott RuttJan 17, 2020 7:00 PM EST
PRESS RELEASESPfizer's Greenstone And Digital Men's Health Clinic Roman Collaborate To Offer Patients Remote Access To The Only FDA-Approved Authorized Generic Version Of Viagra® (sildenafil Citrate)By Business WireJan 23, 2020 6:45 AM EST
JIM CRAMERUsing Technical Analysis: Cramer's 'Mad Money' Recap (Friday 1/17/20)By Scott RuttJan 17, 2020 7:00 PM EST
PRESS RELEASESInsilico Enters Into Research Collaboration With Pfizer Inc. To Explore Novel Data And Artificial Intelligence System For Potential Therapeutic TargetsBy PR NewswireJan 14, 2020 8:30 AM EST
JIM CRAMERThe Language of Wall Street: Cramer's 'Mad Money' Recap (Thursday 1/2/20)By Scott RuttJan 2, 2020 7:18 PM EST
STOCKSDow Jones Stock Market Losers Starting 2020 With a HangoverBy Danny PetersonJan 2, 2020 1:11 PM EST
INVESTINGWhat Is a Payout Ratio and How Do You Calculate It?By Brian O'ConnellDec 30, 2019 6:41 PM EST
STOCKSAbbVie Affirmed Overweight at Piper Jaffray on Potential of Arthritis DrugBy Tony OwusuDec 3, 2019 10:06 AM EST
MARKETSDow, S&P 500 and Nasdaq Again Finish at Record Closing HighsBy Rob LenihanNov 27, 2019 4:17 PM EST
STOCKSMerck Wins Drug Approval and Part of a Court Case; Here's How to Trade the StockBy Jonas ElmerrajiNov 27, 2019 12:59 PM EST
MARKETSStocks End Higher as Trump Says Trade Deal with China 'Potentially Very Close'By Rob LenihanNov 22, 2019 4:18 PM EST
MARKETSDow Ends Above 28,000; Stocks at Records on Trade-Deal HopesBy Rob LenihanNov 15, 2019 4:26 PM EST
STOCKSPfizer's Long-Term Outlook Is Murky, Says UBS on Lowering Price TargetBy Tony OwusuNov 7, 2019 10:32 AM EST
EARNINGSMylan Posts Stronger-Than-Expected Third-Quarter Profit, Reiterates ForecastBy M. Corey GoldmanNov 5, 2019 9:35 AM EST
MARKETSFiat Chrysler, Fed, Apple, AMD, GE - 5 Things You Must Know WednesdayBy Joseph WoelfelOct 30, 2019 7:31 AM EDT
MARKETSDow Ends Lower; S&P 500 Slips After Intraday Record on Strong Pharma EarningsBy Rob LenihanOct 29, 2019 4:23 PM EDT
EARNINGSPfizer Tops Q3 Earnings Forecast, Boosts Full Year Profit Guidance: Shares GainBy Martin BaccardaxOct 29, 2019 10:28 AM EDT
